Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids as Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease
2018 ◽
Vol 24
(3)
◽
pp. S81
◽
Keyword(s):
Phase Ii
◽
1991 ◽
Vol 34
(2)
◽
pp. 97-102
◽
2015 ◽
Vol 21
(5)
◽
pp. 906-912
◽